Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 46 AL 60

Immunomodulatory role of mesenchymal stem cells in Alzheimer's disease

Zhang L, Dong ZF, Zhang JY.

Life Sci. 2020 Apr 1;246:117405. doi: 10.1016/j.lfs.2020.117405. Epub 2020 Feb 5.

Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease?

Ceyzériat K, Tournier BB, Millet P, Frisoni GB, Garibotto V, Zilli T.

J Alzheimers Dis. 2020;74(2):411-419. doi: 10.3233/JAD-190984.

Passive antiamyloid immunotherapy for Alzheimer's disease

Loureiro JC, Pais MV, Stella F, Radanovic M, Teixeira AL, Forlenza OV, de Souza LC.

Curr Opin Psychiatry. 2020 May;33(3):284-291. doi: 10.1097/YCO.0000000000000587.

If Scotland can, why not England?

Benison L.

Br J Community Nurs. 2020 Feb 2;25(2):57. doi: 10.12968/bjcn.2020.25.2.57.

US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development

Morant AV, Vestergaard HT, Lassen AB, Navikas V.

Clin Transl Sci. 2020 Jul;13(4):652-664. doi: 10.1111/cts.12755. Epub 2020 Mar 3.

Alzheimer's disease: targeting the glutamatergic system

Conway ME.

Biogerontology. 2020 Jun;21(3):257-274. doi: 10.1007/s10522-020-09860-4. Epub 2020 Feb 11.

Acute cholinergic syndrome in a patient taking the prescribed dose of donepezil for Alzheimer's disease

Hanazawa T, Kamijo Y, Yoshizawa T, Fujita Y, Usui K, Haga Y.

Psychogeriatrics. 2020 Jul;20(4):538-539. doi: 10.1111/psyg.12531. Epub 2020 Feb 17.

Lipid Nanoparticles as Carriers for the Treatment of Neurodegeneration Associated with Alzheimer's Disease and Glaucoma: Present and Future Challenges

López ES, Machado ALL, Vidal LB, González-Pizarro R, Silva AD, Souto EB.

Curr Pharm Des. 2020;26(12):1235-1250. doi: 10.2174/1381612826666200218101231.

Disease Modification in Alzheimer's Disease: Current Thinking

Liu-Seifert H, Schumi J, Miao X, Tian Y, Rabbia M, Andersen SW, Wilson S, Li W, Entsuah R.

Ther Innov Regul Sci. 2020 Mar;54(2):396-403. doi: 10.1007/s43441-019-00068-4. Epub 2020 Jan 6.

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study

Nagata T, Shinagawa S, Yoshida K, Noda Y, Shigeta M, Mimura M, Nakajima S.

J Clin Psychiatry. 2020 Feb 11;81(2):19m12961. doi: 10.4088/JCP.19m12961.

[Gene-specific treatment approaches in Alzheimer's disease and other tauopathies]

Feneberg E, Otto M.

Nervenarzt. 2020 Apr;91(4):312-317. doi: 10.1007/s00115-020-00872-6.

Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer's Disease

Wuli W, Tsai ST, Chiou TW, Harn HJ.

Int J Mol Sci. 2020 Feb 16;21(4):1327. doi: 10.3390/ijms21041327.

LW-AFC, a new formula from the traditional Chinese medicine Liuwei Dihuang decoction, as a promising therapy for Alzheimer's disease: Pharmacological effects and mechanisms

Cheng X, Huang Y, Zhang Y, Zhou W.

Adv Pharmacol. 2020;87:159-177. doi: 10.1016/bs.apha.2019.10.005. Epub 2020 Jan 3.

Lemborexant: First Approval

Scott LJ.

Drugs. 2020 Mar;80(4):425-432. doi: 10.1007/s40265-020-01276-1.

Targeting Post-Translational Remodeling of Ryanodine Receptor: A New Track for Alzheimer's Disease Therapy?

Chami M, Checler F.

Curr Alzheimer Res. 2020;17(4):313-323. doi: 10.2174/1567205017666200225102941.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias